1. Home
  2. NPO vs IMVT Comparison

NPO vs IMVT Comparison

Compare NPO & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enpro Inc.

NPO

Enpro Inc.

HOLD

Current Price

$251.48

Market Cap

5.7B

Sector

Industrials

ML Signal

HOLD

Logo Immunovant Inc.

IMVT

Immunovant Inc.

HOLD

Current Price

$23.58

Market Cap

5.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NPO
IMVT
Founded
2002
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7B
5.0B
IPO Year
2002
2019

Fundamental Metrics

Financial Performance
Metric
NPO
IMVT
Price
$251.48
$23.58
Analyst Decision
Buy
Buy
Analyst Count
3
9
Target Price
$278.33
$30.78
AVG Volume (30 Days)
188.1K
932.9K
Earning Date
05-05-2026
02-06-2026
Dividend Yield
0.51%
N/A
EPS Growth
N/A
N/A
EPS
1.91
N/A
Revenue
$1,532,000,000.00
N/A
Revenue This Year
$12.31
N/A
Revenue Next Year
$6.39
N/A
P/E Ratio
$131.22
N/A
Revenue Growth
16.98
N/A
52 Week Low
$133.50
$12.72
52 Week High
$286.35
$29.25

Technical Indicators

Market Signals
Indicator
NPO
IMVT
Relative Strength Index (RSI) 47.16 32.65
Support Level $210.31 $21.74
Resistance Level $286.35 $24.63
Average True Range (ATR) 9.91 1.07
MACD -1.80 -0.33
Stochastic Oscillator 52.51 1.68

Price Performance

Historical Comparison
NPO
IMVT

About NPO Enpro Inc.

Enpro Inc formerly EnPro Industries Inc is a United States-based company that designs, develops, manufactures, and markets proprietary engineered industrial products. The company operates through three segments: Sealing Technologies, which derives maximum revenue, manufactures and markets sealing products, wheel-end components & systems; and Advanced Surface Technologies manufactures wafer processing sub-systems, thin-film coatings, optical filters, and other services like cleaning, coating, testing, and refurbishment. Its geographical segments are the United States, Europe, and other foreign countries.

About IMVT Immunovant Inc.

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.

Share on Social Networks: